Virtu Financial LLC Kodiak Sciences Inc. Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$7.57 - $12.5 $132,792 - $219,275	17,542 New	17,542 $136,000
Q2 2022 Aug 09, 2022	SELL	$5.04 - $9.48 $91,123 - $171,398	-18,080 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$7.09 - $89.45 $128,187 - $1.62 Million	18,080 New	18,080 $140,000
Q2 2021 Sep 17, 2021	SELL	$77.2 - $126.54 $246,268 - $403,662	-3,190 Closed	0 $0
Q1 2021 May 19, 2021	SELL	$110.45 - $164.47 $13,143 - $19,571	-119 Reduced 3.6%	3,190 $362,000
Q4 2020 Feb 24, 2021	BUY	$60.78 - $154.03 $201,121 - $509,685	3,309 New	3,309 $486,000
Q3 2020 Dec 11, 2020	SELL	$45.05 - $59.27 $297,014 - $390,767	-6,593 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$42.74 - $66.25 $101,678 - $157,608	2,379 Added 56.45%	6,593 $357,000
Q4 2019 Feb 04, 2020	BUY	$13.9 - $76.65 $58,574 - $323,003	4,214 New	4,214 $303,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.